Andrzej Bojarski
Andrzej Bojarski
Verified email at
Cited by
Cited by
GPCRdb in 2018: adding GPCR structure models and ligands
G Pándy-Szekeres, C Munk, TM Tsonkov, S Mordalski, K Harpsøe, ...
Nucleic acids research 46 (D1), D440-D446, 2018
GPCRdb: an information system for G protein-coupled receptors
V Isberg, S Mordalski, C Munk, K Rataj, K Harpsøe, AS Hauser, B Vroling, ...
Nucleic acids research 44 (D1), D356-D364, 2016
GPCRdb: the G protein‐coupled receptor database–an introduction
C Munk, V Isberg, S Mordalski, K Harpsøe, K Rataj, AS Hauser, P Kolb, ...
British Journal of Pharmacology 173 (14), 2195-2207, 2016
Structure-activity relationship studies of CNS agents. Part 9: 5-HT1A and 5-HT2 receptor affinity of some 2-and 3-substituted 1, 2, 3, 4-tetrahydro-beta-carbolines.
AJ Bojarski, MT Cegła, S Charakchieva-Minol, MJ Mokrosz, M Maćkowiak, ...
Die Pharmazie 48 (4), 289-294, 1993
Homology Modeling of the Serotonin 5-HT1A Receptor Using Automated Docking of Bioactive Compounds with Defined Geometry
M Nowak, M Kołaczkowski, M Pawłowski, AJ Bojarski
Journal of medicinal chemistry 49 (1), 205-214, 2006
Synthesis of New Arylpiperazinylalkylthiobenzimidazole, Benzothiazole, or Benzoxazole Derivatives as Potent and Selective 5-HT1A Serotonin Receptor Ligands
MA Siracusa, L Salerno, MN Modica, V Pittalà, G Romeo, ME Amato, ...
Journal of medicinal chemistry 51 (15), 4529-4538, 2008
Functional selectivity and antidepressant activity of serotonin 1A receptor ligands
Z Chilmonczyk, AJ Bojarski, A Pilc, I Sylte
International journal of molecular sciences 16 (8), 18474-18506, 2015
Receptor-Based Pharmacophores for Serotonin 5-HT7R AntagonistsImplications to Selectivity
M Kołaczkowski, M Nowak, M Pawłowski, AJ Bojarski
Journal of medicinal chemistry 49 (23), 6732-6741, 2006
Antidepressant and antipsychotic activity of new quinoline-and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT1A/5-HT2A/5-HT7 and dopamine D2/D3 receptors
P Zajdel, K Marciniec, A Maślankiewicz, K Grychowska, G Satała, ...
European Journal of Medicinal Chemistry 60, 42-50, 2013
Protective effect of 1-methyl-1, 2, 3, 4-tetrahydroisoquinoline against dopaminergic neurodegeneration in the extrapyramidal structures produced by intracerebral injection of …
L Antkiewicz-Michaluk, J Wardas, J Michaluk, I Romańska, A Bojarski, ...
International Journal of Neuropsychopharmacology 7 (2), 155-163, 2004
The influence of negative training set size on machine learning-based virtual screening
R Kurczab, S Smusz, AJ Bojarski
Journal of cheminformatics 6 (1), 1-9, 2014
Quinoline-and isoquinoline-sulfonamide analogs of aripiprazole: novel antipsychotic agents?
P Zajdel, A Partyka, K Marciniec, AJ Bojarski, M Pawlowski, ...
Future medicinal chemistry 6 (1), 57-75, 2014
Synthesis and activity of substituted 2-phenylquinolin-4-amines, antagonists of immunostimulatory CpG-oligodeoxynucleotides
L Strekowski, M Say, M Henary, P Ruiz, L Manzel, DE Macfarlane, ...
Journal of medicinal chemistry 46 (7), 1242-1249, 2003
1-Methyl-1, 2, 3, 4-tetrahydroisoquinoline protects against rotenone-induced mortality and biochemical changes in rat brain
L Antkiewicz-Michaluk, B Karolewicz, I Romańska, J Michaluk, AJ Bojarski, ...
European journal of pharmacology 466 (3), 263-269, 2003
Quinoline-and isoquinoline-sulfonamide derivatives of LCAP as potent CNS multi-receptor—5-HT1A/5-HT2A/5-HT7 and D2/D3/D4—agents: The synthesis and pharmacological evaluation
P Zajdel, K Marciniec, A Maślankiewicz, G Satała, B Duszyńska, ...
Bioorganic & medicinal chemistry 20 (4), 1545-1556, 2012
Robust optimization of SVM hyperparameters in the classification of bioactive compounds
WM Czarnecki, S Podlewska, AJ Bojarski
Journal of cheminformatics 7 (1), 1-15, 2015
Synthesis of 4‐substituted 2‐(4‐methylpiperazino)pyrimidines and quinazoline analogs as serotonin 5‐HT2A receptor ligands
J Saczewski, A Paluchowska, J Klenc, E Raux, S Barnes, S Sullivan, ...
Journal of Heterocyclic Chemistry 46 (6), 1259-1265, 2009
Novel 1H-Pyrrolo[3,2-c]quinoline Based 5-HT6 Receptor Antagonists with Potential Application for the Treatment of Cognitive Disorders Associated with …
K Grychowska, G Satała, T Kos, A Partyka, E Colacino, ...
ACS Chemical Neuroscience 7 (7), 972-983, 2016
Pharmacophore models for metabotropic 5-HT receptor ligands
AJ Bojarski
Current topics in medicinal chemistry 6 (18), 2005-2026, 2006
Synthesis, anticonvulsant activity and 5-HT1A, 5-HT2A receptor affinity of new N-[(4-arylpiperazin-1-yl)-alkyl] derivatives of 2-azaspiro [4.4] nonane and [4.5] decane-1, 3-dione
J Obniska, M Kołaczkowski, AJ Bojarski, B Duszyńska
European journal of medicinal chemistry 41 (7), 874-881, 2006
The system can't perform the operation now. Try again later.
Articles 1–20